Denmark vs Rwanda: Access to anti-retroviral drugs, male
Denmark
93.0%
in 2023
Rwanda
95.0%
in 2024
Denmark rank
7th
Rwanda rank
4th
Access to anti-retroviral drugs, male over time
- Denmark
- Rwanda
How they compare
Rwanda currently reports 95.0% against 93.0% in Denmark, a difference of 2.0%.
The two have swapped places 1 time across 24 shared years of data; in 2000 it was Denmark ahead.
Denmark ranks 7th and Rwanda ranks 4th of 141 countries.
Denmark has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Denmark | Rwanda | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 49.4% | 10.4% | 39.0% | Denmark |
| 2010s | 77.6% | 60.0% | 17.6% | Denmark |
| 2020s | 91.2% | 88.8% | 2.5% | Denmark |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Denmark or Rwanda?
- Rwanda, at 95.0% against 93.0% in Denmark as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Denmark and Rwanda?
- 2.0%, with Rwanda ahead.
- How many years of comparable data are there for Denmark and Rwanda?
- 24 years are reported by both, from 2000 to 2023.
- How do Denmark and Rwanda rank globally for access to anti-retroviral drugs, male?
- Denmark ranks 7th and Rwanda ranks 4th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.